Advertisement

Pain Relief in Persons with Substance Use and Addictive Disorders

  • Boleslav KosharskyyEmail author
Chapter

Abstract

The challenge of managing pain in patients with substance use and addictive disorders is receiving considerable attention. The increased prevalence of patients with addiction merits a deeper understanding of how clinicians can effectively manage pain in this population. In this chapter we explore the underlying mechanisms of addiction and how these interact with various pain syndromes. Ultimately, the analgesic response to medications and appropriateness for opioids, in particular, is varied but predictors can help determine treatment. The chapter also focuses on some of the issues that limit effective access of appropriate care for patients with pain and addiction.

Keywords

Addiction Opioids Substance use Acute pain Chronic pain Opioid induced hyperalgesia (OIH) 

References

  1. 1.
    Benson H, Raja S, Liu S, Fishman S, Cohen S. Essentials of pain medicine. 3rd ed. Amsterdam: Elsevier Saunders; 2011.Google Scholar
  2. 2.
    American Psychiatric Association Substance Related and Addictive Disorders. 2013. https://dsm.psychiatryonline.org/doi/10.1176/appi.books.9780890425596.dsm16. Accesssed 8 May 2018.
  3. 3.
    Kalivas PW. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci. 2009;10:561–72.CrossRefGoogle Scholar
  4. 4.
    Mistry CJ, Bawor M, Desai D, Marsh DC, Samaan Z. Genetics of opioid dependence: a review of the genetic contribution to opioid dependence. Curr Psychiatr Rev. 2014;10(2):156–67.CrossRefGoogle Scholar
  5. 5.
    Volkow ND, McLellan AT. Opioid abuse in chronic pain–misconceptions and mitigation strategies. N Engl J Med. 2016;374:1253–63.CrossRefGoogle Scholar
  6. 6.
    Elman I, Borsook D. Common brain mechanisms of chronic pain and addiction. Neuron. 2016;89:11–36.CrossRefGoogle Scholar
  7. 7.
    Chang L, Alicata D. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction. 2007;102(Supp 1):16–32.CrossRefGoogle Scholar
  8. 8.
    Hashmi JA, Baliki MN. Shape-shifting pain: chronification of back pain shifts brain representation from nociceptive to emotional circuits. Brain. 2013;136(pt 9):2751–68.CrossRefGoogle Scholar
  9. 9.
    Vasson-Presseau E, Tetrault E. Corticolimbic anatomic characteristics predetermine risk for chronic pain. Brain. 2016;139(pt 7):1958–70.CrossRefGoogle Scholar
  10. 10.
    Saxon AJ, et al. Genetic determinants of addiction to opioids and cocaine. Harv Rev Psychiatry. 2005;13:218–46.CrossRefGoogle Scholar
  11. 11.
    Savage SR, Horvath R. Opioid therapy of pain. In: Ries R, editor. Principles of addiction medicine. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 1329–53.Google Scholar
  12. 12.
    Rockvill MD. Substance abuse and mental health administration office of applied studies. Results from the 2007 national survey on drug use and health: national findings. 2008. NSDUH series H-34, DHHS publication No. SMA 08-4343.Google Scholar
  13. 13.
    Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths — United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65:1445–52.CrossRefGoogle Scholar
  14. 14.
    Ling W, et al. Prescription opiod abuse, pain and addiction: clinical issues and implications. Drug Alcohol Rev. 2011;30:300–5.CrossRefGoogle Scholar
  15. 15.
    Weaver M, Schnoll S. Abuse liability in opioid therapy for pain treatment in patients with an addiction history. Clin J Pain. 2002;18:S61–9.CrossRefGoogle Scholar
  16. 16.
    Edlund MH, et al. Do users of regularly prescribed opioids have higher rates of substance abuse problems than nonusers? Pain Med. 2007;8:647–56.CrossRefGoogle Scholar
  17. 17.
    Passik SD, et al. The interface between pain and drug abuse and the evolution of strategies to optimize pain management while minimizing drug abuse. Exp Clin Psychopharmacol. 2008;16:400–4.CrossRefGoogle Scholar
  18. 18.
    Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6(6):432–42.CrossRefGoogle Scholar
  19. 19.
    Seymour M, Pattersen S. Estimating the prevalence of chronic pain in a given geographical area. J Observational Pain Med. 2014;1(3):15–19.Google Scholar
  20. 20.
    Lohman D, Shleifer R, et al. Access to pain treatment as a human right. BMC Med. 2010;8:8.CrossRefGoogle Scholar
  21. 21.
    Woods B. A comprehensive approach to pain management. Addiction Professional. 2011;9(1):14–6.Google Scholar
  22. 22.
    Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med. 2005;6(2):107–12.CrossRefGoogle Scholar
  23. 23.
    Peppin JF, Passik SD, Couto JE. Recommendations for urine drug monitoring as a component of opioid therapy in the treatment of chronic pain. Pain Med. 2012;13(7):886–96.CrossRefGoogle Scholar
  24. 24.
    Nadelmann E, LaSalle L. Two steps forward, one step back: current harm reduction policy and politics in the United States. Harm Reduct J. 2017;12(1):37.CrossRefGoogle Scholar
  25. 25.
    Chou R. Clinical guidelines from the APS/AAPS on the use of chronic opioid therapy in chronic non-caner pain: what are the key messages for clinical practice? Pol Arch Med Wewn. 2009;119(7–8):469–77.PubMedGoogle Scholar
  26. 26.
    Heit HA. Buprenorphine: new tricks with an old molecule for pain management. Clin J Pain. 2008;24(2):93–7.CrossRefGoogle Scholar
  27. 27.
    Ling W, Mooney L. Prescription opioid abuse, pain and addiction: clinical issues and implications. Drug Alcohol Rev. 2011;30(3):300–5.CrossRefGoogle Scholar
  28. 28.
    Simmons JC. Pain management: new initiatives arise to provide quality care. Qual Lett Healthc Lead. 2001;13(6):2–11.PubMedGoogle Scholar
  29. 29.
    Prater CD, Zylstra RG. Successful pain management for the recovering addicted patient. Prim Care Companion J Clin Psychiatry. 2002;4(4):125–31.CrossRefGoogle Scholar
  30. 30.
    Al-Hasani R, Bruchas MR. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology. 2011;115:1363–81.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Waldhoer M, Bartlett SE, Whistler JL. Opioid receptors. Annu Rev Biochem. 2004;73:953–90.CrossRefGoogle Scholar
  32. 32.
    Lee M, Silverman S, Hansen H, et al. A comprehensive review of opioid induced hyperalgesia. Pain Physician. 2011;14:145–61.PubMedGoogle Scholar
  33. 33.
    Arout CA, Edens E, Petrakis IL, et al. Targeting opioid-induced hyperalgesia in clinical treatment: neurobiological considerations. CNS Drugs. 2015;29:465.CrossRefGoogle Scholar
  34. 34.
    Silverman SM. Opioid induced hyperalgesia: clinical implications for the pain practitioner. Pain Physician. 2009;12(3):679–84.PubMedGoogle Scholar
  35. 35.
    Savage SR, Schofferman J. Pharmacological therapies for drug and alcohol addictions. In: Miller N, Gold M, editors. Pharmacological therapies of pain in drug and alcohol addictions. New York: Dekker; 1995. p. 373–409.Google Scholar
  36. 36.
    Morgan JP. American opiophobia: customary underutilization of opioid analgesics. Adv Alcohol Subst Abuse. 1985 Fall–1986 Winter;5(1–2):163–73.CrossRefGoogle Scholar
  37. 37.
    Alford DP, Compton P, Samet JH. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med. 2006;144(2):127–34.CrossRefGoogle Scholar
  38. 38.
    Karasz A, Zallman L, Berg K, Gourevitch M, Selwyn P, Arnsten JH. The experience of chronic severe pain in patients undergoing methadone maintenance treatment. J Pain Symptom Manag. 2004;28(5):517–25.CrossRefGoogle Scholar
  39. 39.
    Manfredi PL, Gonzales GR, Cheville AL, Kornick C, Payne R. Methadone analgesia in cancer pain patients on chronic methadone maintenance therapy. J Pain Symptom Manag. 2001;21(2):169–74.CrossRefGoogle Scholar
  40. 40.
    Kelly MA. Addressing the opioid epidemic with multimodal pain management. Am J Orthop (Belle Mead NJ). 2016;45(7):S6–8.Google Scholar
  41. 41.
    Mehta V, Langford R. Acute pain management in opioid dependent patients. Rev Pain. 2009;3(2):10–4.CrossRefGoogle Scholar
  42. 42.
    Savarese JJ, Tabler NG. Multimodal analgesia as an alternative to the risks of opioid monotherapy in surgical pain management. J Healthc Risk Manag. 2017;37:24–30.CrossRefGoogle Scholar
  43. 43.
    Hampel C, Schenk M, Göbel H, et al. Pain therapy in addicted patients. Schmerz. 2006;20(5):445–59.CrossRefGoogle Scholar
  44. 44.
    Arnaudo CL, Andraka-Christou B, Allgood K. Psychiatric co-morbidities in pregnant women with opioid use disorders: prevalence, impact, and implications for treatment. Curr Addict Rep. 2017;4(1):1–13.CrossRefGoogle Scholar
  45. 45.
    Laslo J, Brunner J-M, Burns D, et al. An overview of available drugs for management of opioid abuse during pregnancy. Matern Health Neonatol Perinatol. 2017;3:4.CrossRefGoogle Scholar
  46. 46.
    The American College of Obstetricians and Gynecologists Women’s Health Care Physician. Committee opinion. Number 524, May 2012.Google Scholar
  47. 47.
    Jones HE, Johnson RE, Milio L. Post-cesarean pain management of patients maintained on methadone or buprenorphine. Am J Addict. 2006;15:258–9.CrossRefGoogle Scholar
  48. 48.
    Rowley D, McLean S, O’Gorman A, et al. Review of cancer pain management in patients receiving maintenance methadone therapy. Am J Hosp Palliat Care. 2011;28:183.CrossRefGoogle Scholar
  49. 49.
    Hines S, Theodorou S, Williamson A, et al. Management of acute pain in methadone maintenance therapy in-patients. Drug Alcohol Rev. 2008;27:519.CrossRefGoogle Scholar
  50. 50.
    Prater CD, Zylstra RG, Miller KE. Successful pain management for the recovering addicted patient. Prim Care Companion J Clin Psychiatry. 2002;4:125–31.CrossRefGoogle Scholar
  51. 51.
    The White House: Office of the Press Secretary. Obama administration marks progress in substance use disorder prevention, treatment, recovery, and research. Nov 2016. Retrieved from https://obamawhitehouse.archives.gov/the-press-office/2016/11/30/fact-sheet-obama-administration-marks-progress-substance-use-disorder. 20 Aug 2017.
  52. 52.
    Christie MJ. Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol. 2008;154(2):384–96.  https://doi.org/10.1038/bjp.2008.100.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of AnesthesiologyMontefiore Medical Center and Albert Einstein College of MedicineBronxUSA

Personalised recommendations